Laboratory Corp Of America Holdings

Laboratory Corporation of America Holdings, commonly known as Labcorp, is a leading global healthcare diagnostics company that has significantly expanded its services and capabilities through strategic acquisitions. Founded and headquartered in Burlington, N.C., Labcorp has grown into one of the largest clinical laboratory providers worldwide. The company's acquisition of Covance, Inc. for $6 billion in February 2015 marked a pivotal expansion, combining Covance’s drug development expertise with Labcorp’s medical testing prowess to create a market leader in central laboratory and bioanalysis services. This move also aligned Labcorp’s clinical trials companies under the Covance brand, enhancing its position in the pharmaceutical research and development sector. Further diversifying its offerings, Labcorp acquired Bode Technology Group, Inc., bolstering its forensics and DNA identification testing services. This acquisition, along with the merger of Cellmark Forensics and Bode Technology into Bode Cellmark Forensics, underscored Labcorp’s commitment to serving the forensic, law enforcement, and legal communities globally. The company also strengthened its anatomic pathology capabilities with the acquisition of DIANON Systems, now known as Dianon Pathology, renowned for its expertise in uropathology, dermatopathology, and gastrointestinal pathology. Labcorp’s purchase of Genzyme Genetics from Genzyme Corporation for $1 billion further expanded its services into complex reproductive and oncology testing, operating under the Labcorp Specialty Testing Group banner as Integrated Oncology and Integrated Genetics. Additionally, the acquisition of Esoterix, Inc. and its specialty labs increased Labcorp’s esoteric testing expertise, highlighting its continuous growth and innovation in the healthcare diagnostics and drug development industries.